Skip to content
Newcastle Biomedical Research Centre
  • About
    • Our Vision and Strategy
      • Equality, Diversity and Inclusion
    • Our Governance
    • Our People
      • Leadership Team
      • Research Theme Leads
      • Public Partnership Advisory Group (PPAG)
      • Cross-Cutting Area Leads
      • Core Theme
      • Trainees
    • Our Partnership
    • Our Region
    • Acknowledgement and Branding
  • Our Research
    • Ageing, Sarcopenia and Multimorbidity
      • The Theme
      • Team
      • Impact
      • News and Events
    • Dementia, Mental Health and Neurodegeneration
      • The Theme
      • Team
      • Impact
      • News and Events
      • Lewy Body Dementia Doctoral Training Network
    • Digital Health, Ageing Innovation and Inclusion
      • The Theme
      • Team
      • Impact
      • News and Events
      • Patient and Public Involvement and Engagement
    • Informatics and Precision Care for an Ageing Population
      • The Theme
      • Team
      • Impact
      • News and Events
    • Liver Disease, Multimorbidity and Lifestyle
      • The Theme
      • Team
      • Impact
      • News and Events
    • Musculoskeletal Disease and Inflammation Medicine
      • The Theme
      • Team
      • Impact
      • News and Events
      • PIMS
    • Neuromuscular Disease, Rare Diseases and Mitochondrial Dysfunction
      • The Theme
      • Team
      • Impact
      • News and Events
    • Skin Disease, Oral Disease and Immunogenomics
      • The Theme
      • Team
      • Impact
      • News and Events
  • Patient & Public Involvement
    • Get Involved in Research
    • Public Partnership Advisory Group
    • PPIE Resources for Researchers
  • Industry & Partners
  • Training & Professional Development
    • Our Research Training
    • Resource Hub
    • Opportunities
  • Our Impact
  • News and Events
  • Contact
Back to top Go to content
Newcastle Biomedical Research Centre Logo
  • About
    • Our Vision and Strategy
    • Our Governance
    • Our People
    • Our Partnership
    • Our Region
    • Acknowledgement and Branding
  • Our Research
    • Ageing, Sarcopenia and Multimorbidity
    • Dementia, Mental Health and Neurodegeneration
    • Digital Health, Ageing Innovation and Inclusion
    • Informatics and Precision Care for an Ageing Population
    • Liver Disease, Multimorbidity and Lifestyle
    • Musculoskeletal Disease and Inflammation Medicine
    • Neuromuscular Disease, Rare Diseases and Mitochondrial Dysfunction
    • Skin Disease, Oral Disease and Immunogenomics
  • Patient & Public Involvement
    • Get Involved in Research
    • Public Partnership Advisory Group
    • PPIE Resources for Researchers
  • Industry & Partners
  • Training & Professional Development
    • Our Research Training
    • Resource Hub
    • Opportunities
  • Our Impact
  • News and Events
  • Contact

Liver Disease, Multimorbidity
and Lifestyle

  1. Our Research
  2. Liver Disease, Multimorbidity and Lifestyle
  3. The Theme

Chronic liver disease is a major cause of poor quality of life and is a contributor to excess death, making it a significant concern for both patients and the NHS.

In our liver disease theme, we explore the contribution that the ageing process makes to the biology of liver disease. To do this, we harness the expertise of Newcastle’s world-class ageing biology research.

Theme co-leads are; Quentin Anstee, Professor of Experimental Hepatology and an Honorary Consultant Hepatologist at Newcastle Hospitals. He leads one of the largest MASLD clinical services in the UK.

And Helen Reeves, Professor of Liver Cancer and an Honorary Consultant Hepatologist at Newcastle Hospitals. She leads care for patients with liver disease and cancer in the UK.

 

What we cover in this theme

Newcastle BRC’s Liver Disease Theme studies the following conditions:

  • Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
  • Hepatocellular Carcinoma (HCC)
  • Primary Biliary Cholangitis (PBC)
  • Auto immune hepatitis (AIH)

We are researching the mechanisms behind these conditions in order to find treatments that can improve the quality life and survival of those affected.  

Published Papers

  • A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

    A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis

    Journal: N Engl J Med. 2024 Jul 25;391(4):311-319. doi: 10.1056/NEJMoa2401755. Epub 2024 Jun 7. PMID: 38847460

    Authors: Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, An-stee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R, 1404-0043 Trial Investigators

    Read Paper

  • Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ

    Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ

    Journal: Nat Cell Biol 26, 2075–2083 (2024). doi.org/10.1038/s41556-024-01543-3

    Authors: Kiourtis C, Terradas-Terradas M, Gee LM, May S, Georgakopoulou A, Col-lins AL, O'Sullivan ED, Baird DP, Hassan M, Shaw R, Tan EH, Müller M, Engelmann C, Andreola F, Hsieh YC, Reed LH, Borthwick LA, Nixon C, Clark W, Hanson PS, Sumpton D, Mackay G, Suzuki T, Najumudeen AK, Inman GJ, Campbell A, Barry ST, Quaglia A, Morris CM, LeBeau FEN, Sansom OJ, Kirschner K, Jalan R, Oakley F, Bird TG

    Read Paper

  • Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

    Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma

    Journal: In press. Journal of Hepatology 17/12/2024


    Authors: Cappuyns S, Piqué-Gili M, Esteban-Fabró R, Philips G, Balaseviciute U, Pinyol R, Gris-Olive A, Vandecaveye V, Abril-Fornaguera J, Montironi C, Bassaganyas L, Peix J, Zeitlhoefler M, Mesropian A, Huguet-Pradell J, Haber PK, Figueiredo I, Ioannou G, Gonzalez-Kozlova E, D’Alessio E, Mohr R, Meyer T, Lachenmayer A, Marquardt JU, Reeves HL, Edeline J, Finkelmeier F, Trojan J, Galle PR, Foerster F, Mínguez B, Montal R, Gnjatic S, Pinato DJ, Heikenwalder M, Verslype C, Van Cutsem E, Lam-brechts D, Villanueva A, Dekervel J, M. Llovet JM

    Read Paper

  • Human-correlated genetic HCC models identify combination therapy for precision medicine

    Human-correlated genetic HCC models identify combination therapy for precision medicine

    Journal: Nature 2025. In press

    Authors: Müller M, May S, Hall H, Kendall T, McGarry L, Blukacz L, Nuciforo S, Ja-mieson T, Phinichkusolchit N, Dhayade S, Leslie J, Sprangers J, Malviya G, Mrowinska A, Johnson E, McCain M, Halpin J, Kiourtis C, Geor-gakopoulou A, Nixon C, Clark W, Shaw R, Hedley A, Drake T, Hong Tan E, Neilson M, Murphy D, Lewis D, Reeves H, Mann D, Blyth K, Heim M, Car-lin L, Sansom O, Miller C, Suzuki T, Huguet-Pradell J, Powley I, Officer-Jones L, Pennie R, Esteban-Fabró R, Gris Oliver A, Pinyol R, Skalka G, Hoare M, Clark G, Le Quesne J, Llovet J, Bird T

    Read Paper

  • Is home-based, virtually delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer)

    Is home-based, virtually delivered, group exercise feasible and acceptable for older patients with hepatocellular carcinoma? A non-randomised feasibility study (TELEX-Liver Cancer)

    Journal: BMJ Open. 2024 Jun 12;14(6):e082155. doi: 10.1136/bmjopen-2023-082155. PMID: 38866571

    Authors: Hallsworth K, McCain MV, Fallen-Bailey R, Brown MC, Orange ST, Reeves HL


    Read Paper

Awards

  1. THRIVE project – Tumor-host interactions in liver cancer of childhood and adults

THRIVE is an EU-funded initiative that brings together a strong and multidisciplinary team with 13 partners, from 8 countries, with complementary expertise in liver cancer research and in the use of cutting-edge technologies

Prof. Helen Reeves is leading the evaluation of clinical/molecular features to identify determinant of liver cancer onset and progression (WP2)

  1. NASH-DTA/ADVANCE (£20 million, 2022 to date). Prof Quentin Anstee and the consortium leverages the latest advances in integrative multi-omics technologies to study the pathophysiology of cirrhosis and its downstream complications including hepatic decompensation and HCC.

 

  1. Dr Kate Hallsworth, Physiotherapist and Allied Health Care Professional (AHP)

Supported by the Liver Theme, Dr Kate Hallsworth has secured an NIHR Senior Clinical and Practitioner Research Award – 5 year personal fellowship (NIHR304350). She has also received a NuTH Celebrating Excellence Award for the Active Hospitals Team in the Innovation, Transformation and Research category. She is an integral part of our AHP team, supporting ongoing clinical trials in our region, including ‘How can we improve the detection and management of metabolic dysfunction-associated steatotic liver disease in primary care settings? A qualitative interview study with healthcare professionals’ (running in Teesside). She has led the development and implementation of an innovative AHP-led group education programme for patients with metabolic dysfunction-associated steatotic liver disease at NuTH and she has been invited to be part of the European Association for Study of The Liver (EASL) Nurse and AHP Taskforce (3y tenure).

  1. Dr Laura Haigh, Academic dietician - completed PhD, secured a fellowship, led a study on Food Insecurity in patients with chronic liver disease, presented orally at BSG annual meeting July 2024. Howarth R et alO35 Gut 2024;73:A20-A21.

Additional Resources

placeholder related links block LIVErNORTH: The Charity for Liver Patients

 

Theme Leadership and Contacts

  • Professor Quentin M Anstee

    Theme Co-Lead for Liver Disease, Multimorbidity and Lifestyle

  • A portrait photo of Helen Reeves

    Professor Helen Louise Reeves

    Theme Co-Lead for Liver Disease, Multimorbidity and Lifestyle 

More about the Theme

  • The Theme
  • Team
  • Impact
  • News and Events

Useful Links

Contact us

Our Impact

Acknowledgement

Accessibility Statement

Newcastle Biomedical Research Centre Logo in White

NIHR Newcastle Biomedical Research Centre
Biomedical Research Building
Campus for Ageing and Vitality
Newcastle upon Tyne
NE4 5PL
United Kingdom

Email: Newcastle.BRC@newcastle.ac.uk

Tel: +44(0)1912081148

The NIHR Newcastle Biomedical Research Centre (BRC) is part of the NIHR and hosted by The Newcastle upon Tyne Hospitals NHS Foundation Trust and Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust in partnership with Newcastle University.

Newcastle upon Tyne Hospitals NHS Foundation Trust logo

Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust logo

Newcastle University Logo

Newcastle upon Tyne Hospitals NHS Foundation Trust logo

Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust logo

Newcastle University Logo

Privacy Policy

Cookie Policy

Website by Volute

Icon: This website is powered by 100% renewable energy
Icon: Click here to find out more
Cookies user preferences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Read more
Analytics
Tools used to analyse the data to measure the effectiveness of a website and to understand how it works.
Google Analytics
Accept
Decline
Save preferences